I think there are many things we need to do with the TDR area.
Firstly, We need to establish and improve the pathogen resistance monitoring system, then MDR, XDR or TDR strains can be detected as early as possible.
Secondly, Several research focus on specific resistance, such as, TDR-TB, MRSA, ESBL, VRE, et al, need to be carried out. By this way, we can know why such resistance developed.
Last but not least, new drugs are very important to the clinical threapy.
Wish more suggestion discussed here.
Hapyy new year. |